Hazard Analysis and Risk Assessment in the Development of Biomedical Drug Formulation Equipment

被引:0
作者
David H. Johnson
Martha W. Bidez
Lawrence J. DeLucas
机构
[1] University of Alabama at Birmingham,Department of Biomedical Engineering
[2] University of Alabama at Birmingham,School of Engineering
[3] University of Alabama at Birmingham,Center for Biophysical Science and Engineering
来源
Annals of Biomedical Engineering | 2012年 / 40卷
关键词
Hazard analysis; Risk assessment; Risk reduction; Failure mode effects analysis; ANSI; GEIA; Self-interaction chromatography;
D O I
暂无
中图分类号
学科分类号
摘要
Hazard analysis and risk assessment techniques are utilized within many private sector industries and government agencies, including the medical device and pharmaceutical industry, within a structured process to control human injuries and environmental and property damage. In the U.S. the Federal Drug Administration (FDA) requires a hazard analysis be performed on all medical devices. While there are biomedical engineering applications reported which deal with human hazards in clinical, patient care environment, no previous studies extend these traditional techniques to a university-based, research environment. This study applies a tiered approach to hazard analysis and risk assessment to a biomedical, university-based, research environment in the design of a high throughput platform that screens chemical excipients (additives) for their ability to increase protein solubility. Each design stage (conceptual, preliminary, system, and detailed) requires a unique hazard analysis technique based on available information. The analysis techniques applied here are evaluated for their use in a biomedical research environment where experiment accuracy is a primary concern.
引用
收藏
页码:898 / 906
页数:8
相关论文
共 8 条
[1]  
Bonfant G(2010)Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit J. Nephrol. 23 111-118
[2]  
Chiozza ML(2009)FMEA: a model for reducing medical errors Clin. Chim. Acta 404 75-78
[3]  
Ponzetti C(2004)An improved failure mode effects analysis for hospitals Arch. Pathol. Lab. Med. 128 663-667
[4]  
Krouwer JS(1987)Probabilistic risk analysis and safety regulation in the chemical industry J. Hazard. Mater. 15 97-122
[5]  
Paté-Cornell E(2005)Methods of failure and reliability assessment for mechanical heart pumps Artif. Organs 29 15-25
[6]  
Boykin R(2006)Effects of protein aggregates: an immunologic perspective AAPS J. 8 E501-E507
[7]  
Patel SM(undefined)undefined undefined undefined undefined-undefined
[8]  
Rosenberg AS(undefined)undefined undefined undefined undefined-undefined